rs17110757 in ACOT11 gene and Glioma

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

rs10131032 in AKAP6 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs12076373 in AKT3 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs7572263 in C2orf80 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs10464870 in CCDC26 gene and Glioma

PMID 21531791 2011 Chromosome 7p11.2 (EGFR) variation influences glioma risk.

PMID 19578367 2009 Genome-wide association study identifies five susceptibility loci for glioma.

PMID 19578367 2009 We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)).

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 29743610 2018 Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.

rs10116277 in CDKN2B-AS1 gene and Glioma

PMID 21531791 2011 Chromosome 7p11.2 (EGFR) variation influences glioma risk.

PMID 19578367 2009 Genome-wide association study identifies five susceptibility loci for glioma.

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 22886559 2012 Genome-wide association study of glioma and meta-analysis.

PMID 19578367 2009 We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)).

PMID 29743610 2018 Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs3217992 in CDKN2B-AS1;CDKN2B gene and Glioma

PMID 21531791 2011 Chromosome 7p11.2 (EGFR) variation influences glioma risk.

rs1063192 in CDKN2B;CDKN2B-AS1 gene and Glioma

PMID 21531791 2011 Chromosome 7p11.2 (EGFR) variation influences glioma risk.

PMID 19578367 2009 Genome-wide association study identifies five susceptibility loci for glioma.

rs12021720 in DBT gene and Glioma

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

rs11979158 in EGFR gene and Glioma

PMID 21531791 2011 Using these data, we demonstrate two statistically independent associations between glioma and rs11979158 and rs2252586, at 7p11.2 which encompasses the EGFR gene (population-corrected statistics, P(c) = 7.72 × 10(-8) and 2.09 × 10(-8), respectively).

PMID 29743610 2018 Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs1801591 in ETFA gene and Glioma

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs111696067 in GOLGA3 gene and Glioma

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

rs10852606 in HEATR3 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs12125049 in LINC02778;LOC105378761 gene and Glioma

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

rs3751667 in LMF1 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs10892258 in LOC105369519 gene and Glioma

PMID 21531791 2011 Chromosome 7p11.2 (EGFR) variation influences glioma risk.

rs12230172 in LOC105369844 gene and Glioma

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs11583706 in LOC105373220 gene and Glioma

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

rs10924303 in LOC105373265;KIF26B gene and Glioma

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

rs11163687 in LOC107985037 gene and Glioma

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

rs11706832 in LRIG1 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs1920116 in LRRC31 gene and Glioma

PMID 24908248 2014 Here we identify a new SNP associated with glioma risk, rs1920116 (near TERC), that reached genome-wide significance (Pcombined = 8.3 × 10(-9)) in a meta-analysis of genome-wide association studies (GWAS) of high-grade glioma and replication data (1,644 cases and 7,736 controls).

rs7107785 in MAML2 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs4252707 in MDM4 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs11233250 in MIR4300HG gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs11216930 in PHLDB1 gene and Glioma

PMID 21531791 2011 Chromosome 7p11.2 (EGFR) variation influences glioma risk.

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

PMID 29743610 2018 Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.

PMID 19578367 2009 We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)).

PMID 30714141 2019 Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility.

rs8753 in POLR2A gene and Glioma

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

rs3851634 in POLR3B gene and Glioma

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

rs4774756 in RAB27A gene and Glioma

PMID 30714141 2019 Our findings demonstrate two novel association between the glioma risk region marked by variant rs10842893 and rs4774756) and glioma risk.

rs12752552 in RAVER2 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

PMID 29743610 2018 Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.

rs2562152 in RHBDF1 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs2236507 in RTEL1-TNFRSF6B;RTEL1 gene and Glioma

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

rs2297440 in RTEL1;RTEL1-TNFRSF6B gene and Glioma

PMID 19578367 2009 Genome-wide association study identifies five susceptibility loci for glioma.

PMID 29743610 2018 Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

PMID 19578367 2009 We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)).

PMID 21531791 2011 Chromosome 7p11.2 (EGFR) variation influences glioma risk.

PMID 22886559 2012 Genome-wide association study of glioma and meta-analysis.

PMID 30714141 2019 Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility.

PMID 24908248 2014 Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.

rs7124728 in SHANK2 gene and Glioma

PMID 19578367 2009 Genome-wide association study identifies five susceptibility loci for glioma.

rs2235573 in SLC16A8 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs10494090 in SLC25A24 gene and Glioma

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

rs11166389 in SLC35A3;RNU6-1318P gene and Glioma

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

rs10924690 in SMYD3 gene and Glioma

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

rs10842893 in STK38L gene and Glioma

PMID 30714141 2019 Our findings demonstrate two novel association between the glioma risk region marked by variant rs10842893 and rs4774756) and glioma risk.

rs11598018 in STN1 gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs10069690 in TERT gene and Glioma

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 29743610 2018 Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

PMID 19578367 2009 We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)).

PMID 21531791 2011 Chromosome 7p11.2 (EGFR) variation influences glioma risk.

PMID 22886559 2012 Genome-wide association study of glioma and meta-analysis.

PMID 30714141 2019 Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility.

PMID 21827660 2011 Combinations of newly confirmed Glioma-Associated loci link regions on chromosomes 1 and 9 to increased disease risk.

PMID 24908248 2014 Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.

PMID 19578367 2009 Genome-wide association study identifies five susceptibility loci for glioma.

rs35850753 in TP53 gene and Glioma

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

PMID 29743610 2018 Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.

rs12723208 in TRAF5 gene and Glioma

PMID 19578366 2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

rs17748 in TREH;PHLDB1 gene and Glioma

PMID 21531791 2011 Chromosome 7p11.2 (EGFR) variation influences glioma risk.

PMID 19578367 2009 Genome-wide association study identifies five susceptibility loci for glioma.

rs11599775 in VTI1A gene and Glioma

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

rs648044 in ZBTB16;LOC101928875 gene and Glioma

PMID 26424050 2015 Genome-wide association study identifies multiple susceptibility loci for glioma.

PMID 28346443 2017 Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.